Literature DB >> 20057371

Long-term successful weight loss improves vascular endothelial function in severely obese individuals.

Sherman J Bigornia1, Melanie M Mott, Donald T Hess, Caroline M Apovian, Marie E McDonnell, Mai-Ann Duess, Matthew A Kluge, Antonino J Fiscale, Joseph A Vita, Noyan Gokce.   

Abstract

Obesity is associated with increased cardiovascular risk. Although short-term weight loss improves vascular endothelial function, longer term outcomes have not been widely investigated. We examined brachial artery endothelium-dependent vasodilation and metabolic parameters in 29 severely obese subjects who lost > or =10% body weight (age 45 +/- 13 years; BMI 48 +/- 9 kg/m(2)) at baseline and after 12 months of dietary and/or surgical intervention. We compared these parameters to 14 obese individuals (age 49 +/- 11 years; BMI 39 +/- 7 kg/m(2)) who failed to lose weight. For the entire group, mean brachial artery flow-mediated dilation (FMD) was impaired at 6.7 +/- 4.1%. Following sustained weight loss, FMD increased significantly from 6.8 +/- 4.2 to 10.0 +/- 4.7%, but remained blunted in patients without weight decline from 6.5 +/- 4.0 to 5.7 +/- 4.1%, P = 0.013 by ANOVA. Endothelium-independent, nitroglycerin-mediated dilation (NMD) was unaltered. BMI fell by 13 +/- 7 kg/m(2) following successful weight intervention and was associated with reduced total and low-density lipoprotein cholesterol, glucose, hemoglobin A(1c), and high-sensitivity C-reactive protein (CRP). Vascular improvement correlated most strongly with glucose levels (r = -0.51, P = 0.002) and was independent of weight change. In this cohort of severely obese subjects, sustained weight loss at 1 year improved vascular function and metabolic parameters. The findings suggest that reversal of endothelial dysfunction and restoration of arterial homeostasis could potentially reduce cardiovascular risk. The results also demonstrate that metabolic changes in association with weight loss are stronger determinants of vascular phenotype than degree of weight reduction.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20057371      PMCID: PMC2857970          DOI: 10.1038/oby.2009.482

Source DB:  PubMed          Journal:  Obesity (Silver Spring)        ISSN: 1930-7381            Impact factor:   5.002


  40 in total

1.  Inhibition of phosphatidylinositol 3-kinase enhances mitogenic actions of insulin in endothelial cells.

Authors:  Monica Montagnani; Inga Golovchenko; Injune Kim; Gou Young Koh; Marc L Goalstone; Ameya N Mundhekar; Mette Johansen; Dennis F Kucik; Michael J Quon; Boris Draznin
Journal:  J Biol Chem       Date:  2001-11-13       Impact factor: 5.157

2.  Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.

Authors: 
Journal:  Circulation       Date:  2002-12-17       Impact factor: 29.690

3.  Nitric oxide-dependent vasodilation in human subjects.

Authors:  Joseph A Vita
Journal:  Methods Enzymol       Date:  2002       Impact factor: 1.600

4.  Reduction of inflammatory cytokine concentrations and improvement of endothelial functions in obese women after weight loss over one year.

Authors:  Patrizia Ziccardi; Francesco Nappo; Giovanni Giugliano; Katherine Esposito; Raffaele Marfella; Michele Cioffi; Francesco D'Andrea; Anna Maria Molinari; Dario Giugliano
Journal:  Circulation       Date:  2002-02-19       Impact factor: 29.690

5.  Oral glucose loading acutely attenuates endothelium-dependent vasodilation in healthy adults without diabetes: an effect prevented by vitamins C and E.

Authors:  L M Title; P M Cummings; K Giddens; B A Nassar
Journal:  J Am Coll Cardiol       Date:  2000-12       Impact factor: 24.094

6.  Prognostic role of reversible endothelial dysfunction in hypertensive postmenopausal women.

Authors:  Maria G Modena; Lorenzo Bonetti; Francesca Coppi; Francesca Bursi; Rosario Rossi
Journal:  J Am Coll Cardiol       Date:  2002-08-07       Impact factor: 24.094

7.  Lowering of LDL cholesterol rather than moderate weight loss improves endothelium-dependent vasodilatation in obese women with previous gestational diabetes.

Authors:  Robert Bergholm; Mirja Tiikkainen; Satu Vehkavaara; Marjo Tamminen; Kari Teramo; Aila Rissanen; Hannele Yki-Järvinen
Journal:  Diabetes Care       Date:  2003-06       Impact factor: 19.112

8.  Weight loss in combination with physical activity improves endothelial dysfunction in human obesity.

Authors:  Angela Sciacqua; Mafalda Candigliota; Roberto Ceravolo; Angela Scozzafava; Flora Sinopoli; Andrea Corsonello; Giorgio Sesti; Francesco Perticone
Journal:  Diabetes Care       Date:  2003-06       Impact factor: 19.112

9.  Obesity accelerates the progression of coronary atherosclerosis in young men.

Authors:  Henry C McGill; C Alex McMahan; Edward E Herderick; Arthur W Zieske; Gray T Malcom; Richard E Tracy; Jack P Strong
Journal:  Circulation       Date:  2002-06-11       Impact factor: 29.690

10.  Obesity lowers hyperglycemic threshold for impaired in vivo endothelial nitric oxide function.

Authors:  H G Bohlen; Geoffrey P Nase
Journal:  Am J Physiol Heart Circ Physiol       Date:  2002-07       Impact factor: 4.733

View more
  35 in total

Review 1.  Endothelial dysfunction and coronary artery disease: assessment, prognosis, and treatment.

Authors:  Yasushi Matsuzawa; Amir Lerman
Journal:  Coron Artery Dis       Date:  2014-12       Impact factor: 1.439

2.  Weight loss is associated with improved endothelial dysfunction via NOX2-generated oxidative stress down-regulation in patients with the metabolic syndrome.

Authors:  Francesco Angelico; Lorenzo Loffredo; Pasquale Pignatelli; Teresa Augelletti; Roberto Carnevale; Antonio Pacella; Fabiana Albanese; Ilaria Mancini; Serena Di Santo; Maria Del Ben; Francesco Violi
Journal:  Intern Emerg Med       Date:  2011-04-22       Impact factor: 3.397

3.  Improvement of atherosclerotic markers in non-diabetic patients after bariatric surgery.

Authors:  Mohamed Hassan Saleh; Marcelo Chiara Bertolami; Jorge Eduardo Assef; Mohamed Ibrahim Taha; Wilson de Freitas; Ana Claudia Gomes Petisco; Rodrigo Bellio Mattos Barretto; David Costa Le Bihan; Jose Eduardo Martins Barbosa; Carlos Alberto de Jesus; Amanda Guerra Moraes Rego Sousa
Journal:  Obes Surg       Date:  2012-11       Impact factor: 4.129

Review 4.  Visceral adiposopathy: a vascular perspective.

Authors:  Melissa G Farb; Noyan Gokce
Journal:  Horm Mol Biol Clin Investig       Date:  2015-02

5.  Obesity and cardiovascular disease.

Authors:  Caroline M Apovian; Noyan Gokce
Journal:  Circulation       Date:  2012-03-06       Impact factor: 29.690

Review 6.  Small lipid-binding proteins in regulating endothelial and vascular functions: focusing on adipocyte fatty acid binding protein and lipocalin-2.

Authors:  Yu Wang
Journal:  Br J Pharmacol       Date:  2012-02       Impact factor: 8.739

Review 7.  Endothelial dysfunction in diabetes: pathogenesis, significance, and treatment.

Authors:  Sandra J Hamilton; Gerald F Watts
Journal:  Rev Diabet Stud       Date:  2013-08-10

8.  Consuming a hypocaloric high fat low carbohydrate diet for 12 weeks lowers C-reactive protein, and raises serum adiponectin and high density lipoprotein-cholesterol in obese subjects.

Authors:  Megan R Ruth; Ava M Port; Mitali Shah; Ashley C Bourland; Nawfal W Istfan; Kerrie P Nelson; Noyan Gokce; Caroline M Apovian
Journal:  Metabolism       Date:  2013-09-26       Impact factor: 8.694

9.  Vitamin D and Parathyroid Hormone Relationships with Urinary Nitric Oxide Metabolites and Plasma Isoprostanes in African-Americans.

Authors:  Anna Liza Valiña-Tóth; Zongshan Lai; Shilling Zhang; John M Flack
Journal:  Cardiorenal Med       Date:  2012-07-24       Impact factor: 2.041

10.  Impact of Bariatric Surgery on Long-term Cardiovascular Risk: Comparative Effectiveness of Different Surgical Procedures.

Authors:  Sofia Castro Oliveira; J S Neves; P Souteiro; J Pedro; D Magalhães; V Guerreiro; R Bettencourt-Silva; M M Costa; A Varela; I Barroso; P Freitas; D Carvalho
Journal:  Obes Surg       Date:  2020-02       Impact factor: 4.129

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.